Literature DB >> 20666850

Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.

Gillian Murphy1.   

Abstract

Two families of the Metzincin clan of metalloproteinases, the matrix metalloproteinases and the disintegrin metalloproteinases have attracted much attention as important effectors of cellular interactions with their environment. They appear to play significant roles in the modulation of components of the extracellular matrix, matrix and cell receptors, as well as the cytokines and growth factors and their receptors. Such functions at the 'cutting edge' of cell biology puts these enzymes in pivotal roles in the orchestration of the rapid response of cells to their environment, acting as key switches between different signalling pathways. Inevitably such enzymes should be regarded as suitable targets for therapeutic approaches to many diseases where such pathways become dysregulated. A major challenge to the development of direct inhibitors of catalysis has been the broad structural similarity of the Metzincin catalytic site. More detailed knowledge of active site structures has helped to some extent to resolve the development of more specific chemical inhibitors and selected enzymes are now being targeted. An alternative strategy is the consideration of the role of the extracatalytic domains that are determinants of specificity at a variety of levels. Dissecting the relationships between structure and function of these interaction sites is allowing the development of new approaches to inhibition of enzyme function. Antibodies are proving useful tools in this respect and may pave the way to a novel biologics approach to disease therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20666850      PMCID: PMC2962889          DOI: 10.1111/j.1365-2613.2010.00736.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  91 in total

Review 1.  Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition?

Authors:  Netta Sela-Passwell; Gabriel Rosenblum; Tsipi Shoham; Irit Sagi
Journal:  Biochim Biophys Acta       Date:  2009-05-04

Review 2.  Three-dimensional domain architecture of the ADAM family proteinases.

Authors:  Soichi Takeda
Journal:  Semin Cell Dev Biol       Date:  2008-07-26       Impact factor: 7.727

Review 3.  Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.

Authors:  Miriam Fanjul-Fernández; Alicia R Folgueras; Sandra Cabrera; Carlos López-Otín
Journal:  Biochim Biophys Acta       Date:  2009-07-23

Review 4.  Regulation of the proteolytic disintegrin metalloproteinases, the 'Sheddases'.

Authors:  Gillian Murphy
Journal:  Semin Cell Dev Biol       Date:  2008-09-18       Impact factor: 7.727

Review 5.  Matrix metalloproteinase proteomics: substrates, targets, and therapy.

Authors:  Charlotte J Morrison; Georgina S Butler; David Rodríguez; Christopher M Overall
Journal:  Curr Opin Cell Biol       Date:  2009-07-16       Impact factor: 8.382

Review 6.  A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms.

Authors:  Suneel S Apte
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

Review 7.  The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.

Authors:  Jessica Pruessmeyer; Andreas Ludwig
Journal:  Semin Cell Dev Biol       Date:  2008-09-18       Impact factor: 7.727

8.  MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation.

Authors:  Peter Chen; Laura E Abacherli; Samuel T Nadler; Ying Wang; Qinglang Li; William C Parks
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

9.  A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells.

Authors:  Jessica Pruessmeyer; Christian Martin; Franz M Hess; Nicole Schwarz; Sven Schmidt; Tanja Kogel; Nicole Hoettecke; Boris Schmidt; Antonio Sechi; Stefan Uhlig; Andreas Ludwig
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

10.  Control of promatrilysin (MMP7) activation and substrate-specific activity by sulfated glycosaminoglycans.

Authors:  Hyun-Jeong Ra; Susanna Harju-Baker; Fuming Zhang; Robert J Linhardt; Carole L Wilson; William C Parks
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

View more
  4 in total

1.  ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer.

Authors:  Bo Ma; Qianqian Ma; Chunhui Jin; Xiaohong Wang; Guolei Zhang; Huiying Zhang; Harald Seeger; Alfred O Mueck
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 2.  Invited review: mesenchymal progenitor cells in intramuscular connective tissue development.

Authors:  Z G Miao; L P Zhang; X Fu; Q Y Yang; M J Zhu; M V Dodson; M Du
Journal:  Animal       Date:  2015-09-09       Impact factor: 3.240

3.  Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.

Authors:  Dorte Stautz; Ulla M Wewer; Marie Kveiborg
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

4.  The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP).

Authors:  Nadia Houri; Kuo-Cheng Huang; Josephine Nalbantoglu
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.